Genome editing has advanced at a rapid pace with promising results for treating genetic conditions-but there is always room for improvement.

Researchers have developed a machine learning model that predicts Cas9 proteins that can be tailored with designer properties for therapeutic use.

EditCo Bio, Inc. has announced a strategic licensing agreement with Promega Corporation, granting EditCo access to Promega HiBiT, HaloTag®, and NanoLuc® technologies. These advanced protein-tagging ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room for improvement. A new ...

The global Humanized Mouse and Rat Model Market, valued at US$255.8 million in 2024, is forecasted to grow at a robust CAGR ...

Synthetic biology has transformed yeast from a classical model organism into a highly engineerable chassis for next-generation biomanufacturing. By ...

The U.S. Department of Agriculture reported that on Tuesday, April 8, 2025, China’s National Crop Variety Registration ...

In The State of CRISPR and Genome Editing virtual summit, GEN brings together an outstanding line-up of pioneers and ...

Scientists at the VIB-UGent Center for Plant Systems Biology and VIVES University College have developed a new method to ...

PCR genetic analysis has been in the spotlight since COVID-19, but light is now further facilitating PCR-free methods. Osaka ...

For patients with disorders such as autism and schizophrenia, mutations in the same gene could require different treatments, according to new research from Yale School of Medicine (YSM).